QRxPharma Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:QRxPharma Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12325
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
QRxPharma Ltd (QRxPharma) develops and commercializes treatments for pain management and abuse prevention products. The company’s product portfolio includes late and early stage clinical drug candidates. Its dual opioid product portfolio includes Moxduo IR (Q8003), an immediate release oral capsule for the treatment of acute management of moderate to severe pain; Moxduo IV (Q8012), an intravenous formulation for moderate to severe hospital-based pain; and Moxduo CR (Q8011), a controlled release oral tablet being developed in Phase II clinical trial for the treatment of chronic pain. The company’s abuse deterrent technology called Stealth Beadlets has been developed for controlled release Moxduo formulation. It has operations in the US and Australia. QRxPharma is headquartered in North Sydney, New South Wales, Australia.

QRxPharma Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QRxPharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
QrxPharma Enters Into Agreement With Aesica Formulation For Stealth Beadlets Abuse Deterrence Technology 10
Licensing Agreements 11
QRxPharma Enters Into Licensing Agreement With Teva Pharma For Moxduo 11
QRxPharma Enters Into Licensing Agreement With Aspen Pharma For Moxduo 13
QRxPharma Exercises Option For Licensing Agreement With Aspen Pharma For Moxduo 14
QrxPharma Enters Into Licensing Agreement With Paladin Labs For Moxduo 15
QrxPharma Enters Into Licensing Agreement With Actavis For MoxDuo IR 17
Equity Offering 19
QRxPharma Completes Rights Offering Of Shares For US$3.8 Million 19
QRxPharma Completes Private Placement Of Shares For US$7 Million 21
QRxPharma Ltd – Key Competitors 23
QRxPharma Ltd – Key Employees 24
QRxPharma Ltd – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Joint Venture 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
QRxPharma Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QRxPharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QRxPharma Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
QrxPharma Enters Into Agreement With Aesica Formulation For Stealth Beadlets Abuse Deterrence Technology 10
QRxPharma Enters Into Licensing Agreement With Teva Pharma For Moxduo 11
QRxPharma Enters Into Licensing Agreement With Aspen Pharma For Moxduo 13
QRxPharma Exercises Option For Licensing Agreement With Aspen Pharma For Moxduo 14
QrxPharma Enters Into Licensing Agreement With Paladin Labs For Moxduo 15
QrxPharma Enters Into Licensing Agreement With Actavis For MoxDuo IR 17
QRxPharma Completes Rights Offering Of Shares For US$3.8 Million 19
QRxPharma Completes Private Placement Of Shares For US$7 Million 21
QRxPharma Ltd, Key Competitors 23
QRxPharma Ltd, Key Employees 24
QRxPharma Ltd, Subsidiaries 25
QRxPharma Ltd, Joint Venture 25

List of Figures
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[QRxPharma Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Stealth BioTherapeutics Corp (MITO):企業の財務・戦略的SWOT分析
    Stealth BioTherapeutics Corp (MITO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • LG Display Co Ltd:企業の戦略・SWOT・財務情報
    LG Display Co Ltd - Strategy, SWOT and Corporate Finance Report Summary LG Display Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Advanced Digital Broadcast SA:企業の戦略的SWOT分析
    Advanced Digital Broadcast SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Netalogue Technologies plc (NTLP):企業の財務・戦略的SWOT分析
    Summary Netalogue Technologies plc (Netalogue) is a technology company that develops, markets and support e-procurement software systems. The company offers services such as e-commerce solutions, web design, hosting and e-marketing. It solutions include B2B Webstores, B2B/C webstores, B2corp, B2chan …
  • Oragenics Inc (OGEN):製薬・医療:M&Aディール及び事業提携情報
    Summary Oragenics Inc (Oragenics) focuses on the development and commercialization of novel antibiotics against infectious disease that includes treatments for oral mucositis, healthcare associated infections, obesity and dental disorders. The company develops its product candidates based on various …
  • IntelliCell BioSciences Inc:企業の戦略的SWOT分析
    IntelliCell BioSciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • SK Chemicals Co Ltd (006120):企業の財務・戦略的SWOT分析
    Summary SK Chemicals Co Ltd (SK Chemicals) is a provider of chemical and pharmaceutical products. The company offers pharmaceutical drugs to treat erectile dysfunction, arthritis, peptic ulcer, gastroesophageal reflux disease (GERD), cancer and to improve blood circulation. It manufactures green che …
  • Victorian WorkCover Authority:企業の戦略的SWOT分析
    Victorian WorkCover Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Christian Dior SE:企業の戦略・SWOT・財務情報
    Christian Dior SE - Strategy, SWOT and Corporate Finance Report Summary Christian Dior SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Cintas Corp (CTAS):企業の財務・戦略的SWOT分析
    Cintas Corp (CTAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • SSA Marine, Inc.:企業の戦略・SWOT・財務分析
    SSA Marine, Inc. - Strategy, SWOT and Corporate Finance Report Summary SSA Marine, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • ISU ABXIS Co Ltd (086890):製薬・医療:M&Aディール及び事業提携情報
    Summary ISU ABXIS Co Ltd (ISU ABXIS), a subsidiary of ISU Chemical Co Ltd is a biotechnology company that discovers and develops diagnostic products and therapeutic antibodies. The company’s products include fabagal, abcertin, and clotinab. It offers clinical labs, in vitro diagnostics, chemotherapy …
  • Big 5 Sporting Goods Corporation:企業の戦略・SWOT・財務情報
    Big 5 Sporting Goods Corporation - Strategy, SWOT and Corporate Finance Report Summary Big 5 Sporting Goods Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Oil & Gas Development Co Ltd (OGDC)
    Oil & Gas Development Co Ltd (OGDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Bioton SA (BIO):企業の財務・戦略的SWOT分析
    Bioton SA (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Admiral Taverns Ltd:企業の戦略・SWOT・財務分析
    Admiral Taverns Ltd - Strategy, SWOT and Corporate Finance Report Summary Admiral Taverns Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Petro Caribbean Resources Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Petro Caribbean Resources Ltd (Petro Caribbean Resources) is an oil and gas exploration and development company that offers oil and gas exploration and development of petroleum and natural gas reserves. The company owns and operates oil and gas assets located in Putumayo Basin, Colombia. It …
  • Reebok International Ltd.:企業の戦略・SWOT・財務情報
    Reebok International Ltd. - Strategy, SWOT and Corporate Finance Report Summary Reebok International Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Terme Dobrna d.d.:企業の戦略・SWOT・財務情報
    Terme Dobrna d.d. - Strategy, SWOT and Corporate Finance Report Summary Terme Dobrna d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Modern Times Group MTG AB:企業のM&A・事業提携・投資動向
    Modern Times Group MTG AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Modern Times Group MTG AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆